New Drug Keeps Common Breast Cancer Under Control Longer

1 June 2015
Author: Nathan E Botts
Number of views: 31

Adding Ibrance to standard hormone therapy kept disease from progressing for nine months

Source: HealthDay

Categories: Breast Cancer

Tags:

Rate this article:

No rating

Please login or register to post comments.

Health eProfile team members have been at the forefront of developing tools to engage a broad community of patients and people to successfully access, store, and manage their personal health information.

We are dedicated to providing you with a safe and empowering service for storing and exchanging all of your health data.

More Information

If you have any questions, please e-mail us without hesitation. We will reply as quickly as we can.

Phone: (808)-457-0982

Email: [email protected]

Website:
www.healtheservices.com

New Drug Keeps Common Breast Cancer Under Control Longer

Please login or register to post comments.

About Us

Personal Health Data Trending

Tags

Contact